Daxiangbio
Beijing, CN · 1 known investors
Daxiang Bio develops organoid-on-chip technology platforms that combine organoids and organ-on-chip techniques for drug discovery, disease modeling, and precision medicine applications. The company provides organoid-on-chip devices, pre-built models, and technical services for pharmaceutical research and basic research.
BiotechDigital HealthMedical Devices